/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

I

Ian Chi Kei Wong

Aston University(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

1.2K

Papers

31.4K

Citations

85

h-index

540

i10-index

Ian Chi Kei Wong is an academic researcher from Aston University. The author has contributed to research in topics: Pharmaceutical studies and practices & Attention Deficit Hyperactivity Disorder & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 85, co-authored 987 publications.

ORCID: 0000-0001-8242-0014

Research Topics

Pharmaceutical studies and practices Attention Deficit Hyperactivity Disorder SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Pharmaceutical Practices and Patient Outcomes

Papers by this author

works

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers

2015 · Studies in health technology and informatics · 1,144 citations

https://doi.org/10.3233/978-1-61499-564-7-574

George Hripcsak Jon Duke Nigam H. Shah Christian Reich

A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service

2019 · The Lancet Digital Health · 337 citations

https://doi.org/10.1016/s2589-7500(19)30012-3

Valerie Kuan Spiros Denaxas Arturo González-Izquierdo Kenan Direk

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care

2012 · BMC Pediatrics · 217 citations

https://doi.org/10.1186/1471-2431-12-78

Suzanne McCarthy Lynda Wilton Macey L. Murray Paul Hodgkins

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine

2017 · CNS Drugs · 211 citations

https://doi.org/10.1007/s40263-017-0410-7

Leonie Hennissen Mireille J. Bakker Tobias Banaschewski Sara Carucci

Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder

2017 · Journal of Child Psychology and Psychiatry · 196 citations

https://doi.org/10.1111/jcpp.12825

David Daley Saskia Van der Oord Maite Ferrín Samuele Cortese

Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

2022 · The Lancet Digital Health · 172 citations

https://doi.org/10.1016/s2589-7500(22)00187-x

Valerie Kuan Spiros Denaxas Praveetha Patalay Dorothea Nitsch

Research topics

topics

Pharmaceutical studies and practices

Attention Deficit Hyperactivity Disorder

SARS-CoV-2 and COVID-19 Research

COVID-19 Clinical Research Studies

Pharmaceutical Practices and Patient Outcomes

Chat about Author

Papers

Chat

Click to start Chat